Last Gains Seen on Speculative Swine Flu Stocks? (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)
As you will see, the life has been taken out of many of the very speculative swine flu stocks from last week’s highs.
NovaVax, Inc. (NVAX) gained almost 15% to $1.93 today, but this is down about half from last week’s highs of $3.88; shares were at $0.81 before the swine flu scare came out.
Generex Biotechnology Corp. (NASDAQ: GNBT) was up 18% today at $0.438; shares peaked at $0.70 last week and were at $0.27 before the swine flu scare came out.
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) rose 14% to $3.24; shares peaked at $4.89 last week and were at $1.75 before the swine flu scare came out.
Pure Bioscience (NASDAQ: PURE) was down 1.2% at $2,40; shares peaked at $3.19 last week and were at $1.75 before the swine flu scare came out.
Vical Inc (NASDAQ: VICL) fell by 7% to $2.09; shares peaked at $3.30 last week and were at $2.40 before the swine flu scare came out.
Meridian Bioscience Inc. (NASDAQ: VIVO) were up barely above flat at $17.69; shares peaked at $18.30 last week and were at $16.13 before the swine flu scare came out.
AVI BioPharma Inc. (NASDAQ: AVII) was flat at $0.76; shares peaked at $1.29 last week and were at $0.74 before the swine flu scare came out.
Jon C. Ogg
